Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000439595

Medchemexpress LLC Nor-NOHA acetate | 1140844-63-8 | 99.5% | 296.28 | 1 MG
SDP

Catalog No. 5000439595
Encompass_Preferred

nor-NOHA acetate is a selective and reversible Arginase inhibitor. It induces Apoptosis in ARG2-expressing cells under hypoxia and has anti-leukemic activity. This compound also improves liver ischemia-reperfusion injury and can be used in the study of tuberculosis, endothelial dysfunction, immunosuppression, and metabolism.

  • Selective and reversible arginase inhibitor.
  • Induces apoptosis in ARG2-expressing cells under hypoxia.
  • Exhibits anti-leukemic activity.
  • Improves liver ischemia-reperfusion injury.
  • Can be used for studying tuberculosis, endothelial dysfunction, immunosuppression, and metabolism.

Catalog No. 50-004-39595 Supplier Medchemexpress LLC Supplier No. HY112885A1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

nor-NOHA acetate is a selective and reversible Arginase inhibitor. It induces Apoptosis in ARG2-expressing cells under hypoxia and has anti-leukemic activity. This compound also improves liver ischemia-reperfusion injury and can be used in the study of tuberculosis, endothelial dysfunction, immunosuppression, and metabolism.

  • Selective and reversible arginase inhibitor.
  • Induces apoptosis in ARG2-expressing cells under hypoxia.
  • Exhibits anti-leukemic activity.
  • Improves liver ischemia-reperfusion injury.
  • Can be used for studying tuberculosis, endothelial dysfunction, immunosuppression, and metabolism.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.